Causal Role of Delta-beta Coupling for Goal-directed Behavior in Anhedonic Depression
Part of paid clinical trials in Tallahassee, Florida.
- Sponsor
- Florida State University
- Study ID
- NCT06132581
- Status
- Recruiting
Conditions
- Anhedonia
- Major Depressive Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Delta-beta tACS via the Neurocare Direct Current Stimulator Multi-Channel 4 — DEVICEStimulation will be delivered via the Neurocare Direct Current Stimulator Multi-Channel 4, an investigational electrical non-invasive brain stimulation device that is being used for foundational neuroscience and translational research. The electrical waveform for stimulation was designed to mimic delta-beta coupling in the brain.
- Theta-gamma tACS via the Neurocare Direct Current Stimulator Multi-Channel 4 — DEVICEStimulation will be delivered via the Neurocare Direct Current Stimulator Multi-Channel 4, an investigational electrical non-invasive brain stimulation device that is being used for foundational neuroscience and translational research. The electrical waveform for stimulation was designed to mimic theta-gamma coupling in the brain and is used as an active comparator.
- Sham tACS via the Neurocare Direct Current Stimulator Multi-Channel 4 — DEVICEStimulation will be delivered via the Neurocare Direct Current Stimulator Multi-Channel 4, an investigational electrical non-invasive brain stimulation device that is being used for foundational neuroscience and translational research. The electrical waveform is randomly selected to be the theta-gamma or delta-beta waveform, but the stimulation is delivered for only a brief period of time of approximately 30 seconds, which is not sufficient to produce a meaningful dose to the brain. This placebo, or sham, stimulation is designed to mimic the sensation of receiving stimulation.
Study Details
Anhedonia, the inability to seek-out and experience pleasure, is a common symptom in depression that predicts treatment-resistance and is sometimes exacerbated by first-line antidepressants. In our previous research, we found that anhedonia decreases goal-directed behavior and its related neural activity. In this study, we will investigate target engagement from five-consecutive days of stimulation for participants that are within a unipolar major depressive episode and also have high symptoms of anhedonia.
Key Dates
- Start date
- Jan 24, 2024
- Status verified
- Mar 2026
- Primary completion
- Jul 31, 2026
- Completion
- Jul 31, 2026
Study Design
- Enrollment
- 72 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Delta-beta tACSThe study is investigating the use of transcranial alternating current stimulation (tACS). The stimulation is delivered at 1 milliampere (mA) zero-to-peak amplitude at the target electrodes and 2 mA zero to-peak amplitude at the return electrode. For the experimental arm, the tACS will be delivered using the cross-frequency stimulation waveform delta-beta (3-20Hz).
- Active Comparator: Theta-gamma tACSThis arm serves as an active control where tACS will be delivered using the cross-frequency stimulation waveform theta-gamma (5-50Hz).
- Sham Comparator: Active-sham tACSFor active sham stimulation, either delta-beta or theta-gamma stimulation is delivered for 15 seconds only at the beginning and end of the stimulation period. This is intended to mimic the skin sensations (e.g., itching, burning, tingling) that are experienced at the onset and offest of stimulation, assisting with blinding the participant's assignment.
Primary Outcome Measure
Change in coupling strength between prefrontal and posterior cortex [ Time Frame: 1 week ]
Central Contacts
- Justin M Riddle, PhD850-645-2389
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Florida State University | Tallahassee | Florida | 32306 | Justin M Riddle, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Tallahassee, FL
By condition
By specialty
By research site
Related Studies
- Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive DisorderPHASE3 · Recruiting · Intra-Cellular Therapies, Inc. · Huntsville, Alabama
- Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital TherapeuticsRecruiting · AdventHealth · Orlando, Florida
- Multi-Omic, Clinomic and Digitomic Attributes of Major Depression for Integrative AnalyticsEnrolling By Invitation · Mayo Clinic · Jacksonville, Florida
- Study of ALTO-300 in MDDPHASE2 · Recruiting · Alto Neuroscience · Phoenix, Arizona